61Cu-NODAGA-LM3 PET/CT for the Detection of Neuroendocrine Tumors (COPPER PET in NET)

Clinical trial NCT06455358 · RECRUITING

Trial details

NCT number: NCT06455358
Sponsor: University Hospital, Basel, Switzerland
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Neuroendocrine Tumors

Start date: 2025-02-05
Primary completion: 2028-06-01
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.